Online Database of Chemicals from Around the World

(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-2-propyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one
[CAS# 763924-54-5]

Identification
Name (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-2-propyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one
Molecular Structure CAS # 763924-54-5, (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-2-propyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one
Molecular Formula C39H74N2O12
Molecular Weight 763.01
CAS Registry Number 763924-54-5
Properties
Solubility Freely soluble (110 g/L) (25 ºC), Calc.*
Density 1.17±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2016 ACD/Labs)
Market Analysis Reports
List of Reports Available for (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-2-propyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one
Related Products
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[[4,6-Dideoxy-beta-D-erythro-hexopyranos-3-ulos-1-yl]oxy]-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one  1,2-Dideoxy-1-(hydroxymethyl)-3-O-(phenylmethyl)-DL-myo-inositol  Dideoxyinosine  2',3'-Dideoxyinosine 5'-phosphate  2',3'-Dideoxyinosine triphosphate  2',3'-Dideoxy-5-iodocytidine  2,6-Dideoxy-3-C-methyl-D-arabino-hexose  2,4-Dideoxy-3,5-O-(1-methylethylidene)-D-erythrohexonic acid ethyl ester  (1R,2R,3R,6R,7S,8S,9R,10R,12R,15R)-7-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-3-ethyl-2,10-dihydroxy-2,6,8,10,12,15-hexamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-4,16-dioxa-14-azabicyclo[11.2.1]hexadec-13-en-5-one  (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(formylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one  2',5'-Dideoxy-5-methyluridine  D-2,3-Dideoxy-2-myo-inositol 1-[(R)-2-methoxy-3-(octadecyloxy)propyl hydrogen phosphate]  1-(5,6-Dideoxy-6-phosphono-beta-D-ribo-hexofuranosyl)-1H-1,2,4-triazole-3-carboxamide  2,6-Dideoxy-beta-D-ribo-hexopyranose tribenzoate  2',3'-Dideoxy-6-thioinosine  2',3'-Dideoxythymidine  2',3'-Dideoxy-5-[3-[(trifluoroacetyl)amino]-1-propyn-1-yl]cytidine  2',3'-Dideoxy-5-[3-[(trifluoroacetyl)amino]-1-propyn-1-yl]uridine  2',3'-Dideoxyuridine  2',3'-Dideoxyxanthosine